Trial intelligence / Profile preview

Oxytocin in Adult Patients With Prader-Willi Syndrome

NCT01038570Phase 2Completed

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Jun 2009
Primary completion
Sep 2009
Countries
1
01

Overview

A Phase 2 trial of oxytocin nasal spray in Prader-Willi syndrome (PWS), sponsored by Centre hospitalier universitaire de Toulouse. Started Jun 2009; status: completed.

02

Drugs

oxytocin nasal spray
03

Conditions

Prader-Willi syndrome (PWS)

Beyond the preview

Go deeper on NCT01038570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01038570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call